42950sek
-1,3 %
Date:2024-06-19Time:17:29:37Latest report:Q1-2024List:Mid CapTicker:XVIVO
Market Cap:13 529 msekEnterprise Value:13 049 msekNet Sales:642,9 msekEarnings:100,4 msekEmployees:0ISIN:SE0004840718

Ratios

10-year key figure history for Xvivo Perfusion turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Xvivo Perfusion with index and moving average MA50 and MA200.

Stockprice:429,50
MA50:384,05
MA200:304,23
Price/MA200:41,2 %
RSI (14):59,2
Price/MA50:11,8 %

Description

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Medical Equipment